Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Distribution

Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers. The Company"s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising.
Website: cardinalhealth.com



Growth: Bad revenue growth rate -4.5%, there is slowdown compared to average historical growth rates 19.8%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -12.3%

Profitability: LTM EBITDA margin is positive, +1.3%. On average the margin is improving steadily. Gross margin is low, +3.6%. In the last quarter the company beat the estimated EPS, +16.8%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.1 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 1.0%. Free cash flow yield -7.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 205.7% higher than minimum and 1.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.2x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: CAH
Share price, USD:  (0.0%)210.93
year average price 163.66  


year start price 127.37 2025-02-08

min close price 123.93 2025-03-10

max close price 213.73 2025-11-25

current price 210.93 2026-02-07
Common stocks: 272 427 011

Dividend Yield:  1.0%
FCF Yield LTM: -7.4%
EV / LTM EBITDA: 21.2x
EV / EBITDA annualized: 19.8x
Last revenue growth (y/y):  -4.5%
Last growth of EBITDA (y/y):  > +200.0%
Historical revenue growth:  +19.8%
Historical growth of EBITDA:  +46.9%
EV / Sales: 0.3x
Margin (EBITDA LTM / Revenue): 1.3%
Fundamental value created in LTM:
Market Cap ($m): 57 463
Net Debt ($m): 2 297
EV (Enterprise Value): 59 760
Price to Book: -20.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-07seekingalpha.com

Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)

2026-02-06zacks.com

Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

2026-02-05zacks.com

Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates

2026-02-05wsj.com

Cardinal Health Lifts Outlook After Posting Higher Profit

2026-02-05prnewswire.com

Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

2026-02-04zacks.com

Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings

2026-02-03zacks.com

Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?

2026-02-02zacks.com

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

2026-02-02zacks.com

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

2026-01-23zacks.com

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371
fillingDate 2025-10-03 2024-11-01 2024-05-02 2024-02-01 2023-11-03 2023-05-04 2023-02-02 2022-11-04
acceptedDate 2025-10-03 06:25:39 2025-08-12 08:58:00 2024-11-01 08:58:41 2024-08-14 08:47:07 2024-05-02 08:47:36 2024-02-01 08:54:23 2023-11-03 08:45:54 2023-08-15 08:50:31 2023-05-04 16:25:56 2023-02-02 16:19:17 2022-11-04 09:11:57 2022-08-11 16:17:06 2021-08-16 08:50:00
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
revenue 64 009M 222 578M 52 277M 226 827M 54 911M 57 445M 54 763M 204 979M 50 487M 51 469M 49 603M 181 326M 162 467M
costOfRevenue 61 690M 214 410M 50 375M 219 413M 53 028M 55 599M 52 995M 198 105M 48 702M 49 806M 47 989M 174 842M 155 689M
grossProfit 2 319M 8 168M 1 902M 7 414M 1 883M 1 846M 1 768M 6 889M 1 785M 1 663M 1 614M 6 484M 6 778M
grossProfitRatio 0.036 0.036 0.034 0.032 0.032 0.035 0.032 0.033
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 1 461M 5 382M 1 277M 5 000M 1 282M 1 283M 1 197M 0 1 179M 1 191M 1 197M 0 4 533M
sellingGeneralAndAdministrativeExpenses 1 461M 5 382M 1 277M 5 000M 1 282M 1 283M 1 197M 4 800M 1 179M 1 191M 1 197M 4 512M 4 533M
otherExpenses 190M 511M 0 1 171M 7M 16M 2M 1 322M 74M 71M 71M 2 579M 1 773M
operatingExpenses 1 651M 5 893M 1 277M 6 171M 1 282M 1 346M 1 261M 6 122M 1 253M 1 262M 1 268M 7 091M 6 306M
costAndExpenses 63 341M 220 303M 51 709M 225 584M 54 310M 56 945M 54 256M 204 227M 49 955M 51 068M 49 257M 181 933M 161 995M
interestIncome 0 0 0 0 0 8M 14M 0 0 0 0 0 0
interestExpense 80M 215M 32M 51M 33M 8M 14M 84M 28M 25M 25M 147M 180M
depreciationAndAmortization 233M 790M 182M 710M 177M 175M 172M 692M 135M 170M 171M 692M 783M
ebitda 911M 3 106M 755M 1 962M 778M 691M 681M 1 439M 707M 578M 515M 55M 1 286M
ebitdaratio 0.014 0.014 0.014 0.012 0.012 0.014 0.011 0.01
operatingIncome 668M 2 275M 568M 1 243M 601M 482M -14M 752M 572M 408M 344M -607M 472M
operatingIncomeRatio 0.01 0.011 0.011 0.008 -0 0.011 0.008 0.007
totalOtherIncomeExpensesNet -70M -174M -27M -42M -260M -2M -519M -89M -28M -545M -234M -177M -149M
incomeBeforeTax 598M 2 101M 541M 1 201M 341M 490M -26M 663M 544M -137M 110M -784M 323M
incomeBeforeTaxRatio 0.009 0.01 0.006 0.009 -0 0.011 -0.003 0.002
incomeTaxExpense 144M 532M 124M 348M 82M 136M -32M 332M 197M -7M -1 000 000 153M -289M
netIncome 450M 1 561M 416M 852M 258M 353M 5M 330M 345M -130M 110M -938M 611M
netIncomeRatio 0.007 0.008 0.005 0.006 0 0.007 -0.003 0.002
eps 1.89 6.48 1.71 3.48 1.06 1.44 0.02 1.26 1.35 -0.5 0.41 -3.34 2.09
epsdiluted 1.88 1.7 1.05 1.44 0.02 1.34 -0.5 0.4
weightedAverageShsOut 238M 241M 243M 245M 243M 245M 249M 261M 256M 261M 271M 279M 292M
weightedAverageShsOutDil 239M 242M 245M 247M 245M 246M 250M 262M 258M 261M 273M 279M 294M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-12 2024-08-14 2023-08-15 2022-08-11 2021-08-16
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -215M -51M -84M -147M -180M
ebit 2 316M 1 252M 747M -637M 503M
nonOperatingIncomeExcludingInterest -41M -9M 5M 30M -31M
netIncomeFromContinuingOperations 1 569M 853M 331M -937M 612M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 1 561M 852M 330M -938M 611M
epsDiluted 6.45 3.45 1.26 -3.34 2.08

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371
fillingDate 2025-10-03 2024-11-01 2024-05-02 2024-02-01 2023-11-03 2023-05-04 2023-02-02 2022-11-04
acceptedDate 2025-10-03 06:25:39 2025-08-12 08:58:00 2024-11-01 08:58:41 2024-08-14 08:47:07 2024-05-02 08:47:36 2024-02-01 08:54:23 2023-11-03 08:45:54 2023-08-15 08:50:31 2023-05-04 16:25:56 2023-02-02 16:19:17 2022-11-04 09:11:57 2022-08-11 16:17:06 2021-08-16 08:50:00
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
cashAndCashEquivalents 4 593M 3 874M 2 867M 5 133M 3 718M 4 591M 3 854M 4 076M 3 990M 3 654M 3 492M 4 717M 3 407M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 4 593M 3 874M 2 867M 5 133M 3 718M 4 591M 3 854M 4 076M 3 990M 3 654M 3 492M 4 717M 3 407M
netReceivables 13 770M 13 242M 11 781M 12 084M 11 566M 11 788M 11 265M 11 108M 10 992M 11 421M 11 039M 10 561M 9 103M
inventory 17 559M 16 831M 15 619M 14 957M 17 277M 18 451M 16 987M 16 119M 16 620M 17 263M 15 891M 15 636M 14 594M
otherCurrentAssets 2 615M 2 426M 2 638M 2 710M 3 173M 2 816M 2 582M 72M 1 895M 2 258M 2 274M 0 1 101M
totalCurrentAssets 38 537M 36 373M 32 905M 34 884M 35 734M 37 658M 34 688M 33 737M 33 497M 34 596M 32 696M 32 935M 31 048M
propertyPlantEquipmentNet 2 831M 2 858M 2 535M 2 529M 2 470M 2 446M 2 441M 2 461M 2 362M 2 341M 2 339M 2 361M 2 360M
goodwill 9 711M 9 691M 4 725M 4 725M 4 788M 4 024M 4 025M 4 613M 5 000M 4 986M 5 675M 5 855M 7 989M
intangibleAssets 2 399M 2 486M 1 663M 1 725M 1 719M 1 347M 1 407M 1 472M 1 567M 1 632M 1 692M 1 774M 2 105M
goodwillAndIntangibleAssets 12 110M 12 177M 6 388M 6 450M 6 507M 5 371M 5 432M 6 085M 6 567M 6 618M 7 367M 7 629M 10 094M
longTermInvestments 0 14M 0 43M 20M -8 199M -8 245M 56M 0 0 0 77M 68M
taxAssets 0 0 0 0 8 169M 8 199M 8 245M 0 8 384M 8 797M 0 0 0
otherNonCurrentAssets 1 750M 1 700M 1 231M 1 215M -7 020M 1 098M 1 149M 1 010M -7 433M -7 870M 985M 876M 883M
totalNonCurrentAssets 16 691M 16 749M 10 154M 10 237M 10 146M 8 915M 9 022M 9 612M 9 880M 9 886M 10 691M 10 943M 13 405M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 55 228M 53 122M 43 059M 45 121M 45 880M 46 573M 43 710M 43 349M 43 377M 44 482M 43 387M 43 878M 44 453M
accountPayables 36 860M 34 713M 30 365M 31 759M 32 089M 34 259M 31 540M 29 934M 29 601M 30 083M 28 362M 27 128M 23 700M
shortTermDebt 52M 714M 940M 551M 1 187M 1 188M 788M 892M 26M 577M 578M 682M 976M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 8 797M 8 919M 0 0
otherCurrentLiabilities 3 356M -164M 3 373M 0 3 030M 2 839M 2 737M 42M 2 876M -6 245M -6 300M 0 96M
totalCurrentLiabilities 40 268M 38 897M 34 678M 35 640M 36 306M 38 286M 35 065M 33 740M 32 503M 33 212M 31 559M 30 550M 27 624M
longTermDebt 8 980M 7 820M 4 224M 4 583M 4 667M 3 535M 3 890M 3 850M 4 708M 4 685M 4 689M 4 686M 5 320M
deferredRevenueNonCurrent 0 0 0 0 0 -7 188M -8 246M 0 -8 384M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 8 711M 2 429M 0 3 090M 937M 7 188M 8 245M 3 140M 8 384M 0 8 919M 3 021M 8 315M
otherNonCurrentLiabilities 148M 5 799M 7 433M 4 545M 7 232M 8 199M 8 246M 5 142M 8 384M 8 797M -24 251M 5 890M 981M
totalNonCurrentLiabilities 17 839M 16 859M 11 657M 12 693M 12 836M 11 734M 12 135M 12 566M 13 092M 13 482M 13 608M 14 034M 15 035M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 811M 0 475M 4 667M 3 535M 3 890M 434M 4 708M 4 685M 4 689M 437M 419M
totalLiabilities 57 959M 55 756M 46 335M 48 333M 49 142M 50 020M 47 200M 46 306M 45 595M 46 694M 45 167M 44 584M 42 659M
preferredStock 0 0 0 0 0 0 1 000 000 0 0 0 0 0 0
commonStock 2 746M 2 956M 2 827M 2 917M 2 887M 2 855M 2 728M 2 746M 2 818M 2 747M 2 576M 2 813M 2 806M
retainedEarnings 1 116M 783M 14M -286M -289M -425M -654M -642M -342M -560M -301M -280M 1 205M
accumulatedOtherComprehensiveIncomeLoss -159M -155M -155M -167M -160M -155M -165M -151M -142M -146M -176M -114M -34M
othertotalStockholdersEquity -6 582M -5 963M -5 703M -5 724M -5 400M -4 552M -4 253M -3 880M
totalStockholdersEquity -2 879M -2 781M -3 277M -3 213M -3 265M -3 449M -3 490M -2 958M -2 218M -2 212M -1 781M -709M 1 791M
totalEquity -2 731M -2 634M -3 276M -3 212M -3 262M -3 447M -3 489M -2 957M -2 218M -2 212M -1 781M -706M 1 794M
totalLiabilitiesAndStockholdersEquity 55 228M 43 059M 45 880M 46 573M 43 710M 43 377M 44 483M 43 387M
minorityInterest 148M 147M 1 000 000 1 000 000 3M 2M 1 000 000 1 000 000 2M 1 000 000 0 3M 3M
totalLiabilitiesAndTotalEquity 55 228M 53 122M 43 059M 45 121M 45 880M 46 573M 43 710M 43 349M 43 377M 44 483M 43 387M 43 878M 44 453M
totalInvestments 0 14M 0 43M 20M -8 199M -8 245M 56M 0 0 0 77M 68M
totalDebt 9 032M 9 345M 5 164M 5 609M 5 854M 4 723M 4 678M 5 176M 4 734M 5 262M 5 267M 5 805M 6 715M
netDebt 4 439M 5 471M 2 297M 476M 2 136M 132M 824M 1 100M 744M 1 608M 1 775M 1 088M 3 308M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-12 2024-08-14 2023-08-15 2022-08-11 2021-08-16
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 13 242M 12 084M 11 108M 10 561M 9 103M
otherReceivables 0 0 0 0 0
prepaids 0 0 2 362M 2 021M 2 843M
totalPayables 34 713M 31 759M 29 934M 27 128M 23 700M
otherPayables 0 0 0 0 0
accruedExpenses 3 634M 3 447M 2 972M 2 842M 2 957M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 811M 475M 434M 437M 419M
treasuryStock -6 365M -5 677M -4 911M -3 128M -2 186M
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH CAH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371 721 371
fillingDate 2025-10-03 2024-11-01 2024-05-02 2024-02-01 2023-11-03 2023-05-04 2023-02-02 2022-11-04
acceptedDate 2025-10-03 06:25:39 2025-08-12 08:58:00 2024-11-01 08:58:41 2024-08-14 08:47:07 2024-05-02 08:47:36 2024-02-01 08:54:23 2023-11-03 08:45:54 2023-08-15 08:50:31 2023-05-04 16:25:56 2023-02-02 16:19:17 2022-11-04 09:11:57 2022-08-11 16:17:06 2021-08-16 08:50:00
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
netIncome 454M 1 569M 417M 853M 258M 354M 6M 331M 347M -130M 111M -933M 612M
depreciationAndAmortization 233M 790M 182M 710M 177M 175M 172M 692M 175M 170M 171M 723M 783M
deferredIncomeTax 0 243M 0 -104M 0 0 -720M -40M 0 0 0 7M 496M
stockBasedCompensation 93M 244M 30M 121M 31M 28M 29M 96M 21M 25M 23M 0 89M
changeInWorkingCapital 173M -523M -2 292M 1 510M -616M 617M -228M 457M 778M -208M -464M -2 345M 289M
accountsReceivables -539M -833M 288M -996M 225M -537M 50M -950M 409M -411M -508M -1 405M -904M
inventory -736M -1 816M -678M 1 115M 1 165M -1 479M -1 057M -412M 631M -1 379M -264M -1 204M -1 584M
accountsPayables 2 147M 2 732M -1 394M 1 824M -2 170M 2 719M 1 727M 2 816M -481M 1 720M 1 234M 0 2 325M
otherWorkingCapital -699M -606M -508M -433M 164M -86M -720M -997M 219M -138M -926M 264M 452M
otherNonCashItems 20M 74M 16M 672M 1 266M 15M 1 286M 1 308M 40M 740M 182M 5 670M 160M
netCashProvidedByOperatingActivities 973M 2 397M -1 647M 3 762M -49M 1 189M 545M 2 844M 1 361M 597M 23M 3 122M 2 429M
investmentsInPropertyPlantAndEquipment -108M -547M -90M -511M -112M -114M -92M -481M -109M -85M -70M -387M -400M
acquisitionsNet -41M -5 250M 2M -1 190M -1 184M -18M -29M -10M -10M -2M 2M 901M -3M
purchasesOfInvestments 0 0 0 -550M -1 000 000 -1 000 000 -1 000 000 0 -1 000 000 -2M -3M -78M -22M
salesMaturitiesOfInvestments 5M 202M 0 384M 0 18M 29M 29M 29M 0 1 000 000 100M 47M
otherInvestingActivites 2M 0 -550M 10M 30M 0 2M 0
netCashUsedForInvestingActivites -142M -88M -1 847M -105M -63M -91M -87M -70M
debtRepayment 477M -9M -1 131M -8M -7M -558M -6M -7M
commonStockIssued 0 0 0 0 0 0 0 0
commonStockRepurchased -375M -765M -375M -750M 0 -250M -500M -2 000M -250M -250M -1 000M -1 000M -200M
dividendsPaid -129M -128M -122M -124M -131M -128M -129M -142M
otherFinancingActivites -83M -28M 22M 29M -28M 2M 23M -14M
netCashUsedProvidedByFinancingActivities -110M -540M 1 031M -353M -666M -934M -362M -1 163M
effectOfForexChangesOnCash -2M -3M 9M -9M -8M 6M -5M -8M 0 14M -15M 84M -98M
netChangeInCash 719M -1 259M -2 266M 1 057M -873M 737M -189M -669M 336M 162M -1 225M 1 310M 636M
cashAtEndOfPeriod 4 593M 3 874M 2 867M 5 133M 3 718M 4 591M 3 854M 4 076M 3 990M 3 654M 3 492M 4 717M 3 407M
cashAtBeginningOfPeriod 3 874M 5 133M 5 133M 4 076M 4 591M 3 854M 4 043M 4 745M 3 654M 3 492M 4 717M 3 407M 2 771M
operatingCashFlow 973M 2 397M -1 647M 3 762M -49M 1 189M 545M 2 844M 1 361M 597M 23M 3 122M 2 429M
capitalExpenditure -108M -547M -90M -511M -112M -114M -92M -481M -109M -85M -70M -387M -400M
freeCashFlow 865M 1 850M -1 737M 3 251M -161M 1 075M 453M 2 363M 1 252M 512M -47M 2 735M 2 029M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-12 2024-08-14 2023-08-15 2022-08-11 2021-08-16
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -10M 18M 8M 31M 0
netCashProvidedByInvestingActivities -5 605M -1 849M -454M 567M -378M
netDebtIssuance 3 224M 356M -579M -885M -570M
longTermNetDebtIssuance 3 224M 356M -579M -885M -570M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -765M -750M -2 000M -1 000M -200M
netCommonStockIssuance -765M -750M -2 000M -1 000M -200M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -494M -499M -525M -559M -573M
commonDividendsPaid -494M -499M -525M -559M -573M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -13M 46M 53M -19M 26M
netCashProvidedByFinancingActivities 1 952M -847M -3 051M -2 463M -1 317M
incomeTaxesPaid 444M 191M 156M 0 273M
interestPaid 315M 214M 203M 0 182M

Earning call transcript

2025 q4
2026-02-05 ET (fiscal 2026 q2)
2025 q3
2025-10-30 ET (fiscal 2026 q1)
2025 q2
2025-08-12 ET (fiscal 2025 q4)
2025 q1
2025-05-01 ET (fiscal 2025 q3)
2024 q4
2025-01-30 ET (fiscal 2025 q2)
2024 q3
2024-11-01 ET (fiscal 2025 q1)
2024 q2
2024-08-14 ET (fiscal 2024 q4)
2024 q1
2024-05-02 ET (fiscal 2024 q3)
2023 q4
2024-02-01 ET (fiscal 2024 q2)
2023 q3
2023-11-03 ET (fiscal 2024 q1)
2023 q2
2023-08-15 ET (fiscal 2023 q4)
2023 q1
2023-05-04 ET (fiscal 2023 q3)
2022 q4
2023-02-02 ET (fiscal 2023 q2)
2022 q3
2022-11-04 ET (fiscal 2023 q1)
2022 q2
2022-08-11 ET (fiscal 2022 q4)
2022 q1
2022-05-05 ET (fiscal 2022 q3)
2021 q4
2022-02-03 ET (fiscal 2022 q2)
2021 q3
2021-11-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2026-02-05 08:47 ET
Cardinal Health reported for 2025 q4
SEC form 8
2026-02-05 06:47 ET
Cardinal Health reported for 2025 q4
SEC form 8
2026-02-05 06:47 ET
Cardinal Health published news for 2025 q4
SEC form 8
2026-01-13 11:53 ET
Cardinal Health published news for 2025 q4
SEC form 8
2026-01-13 11:53 ET
Cardinal Health published news for 2025 q4
SEC form 10
2025-10-30 12:48 ET
Cardinal Health reported for 2025 q3
SEC form 8
2025-10-30 10:52 ET
Cardinal Health reported for 2025 q3
SEC form 8
2025-10-30 10:52 ET
Cardinal Health published news for 2025 q3
SEC form 8
2025-10-10 06:33 ET
Cardinal Health published news for 2025 q3
SEC form 8
2025-10-10 06:33 ET
Cardinal Health published news for 2025 q3
SEC form 8
2025-10-03 06:25 ET
Cardinal Health published news for 2025 q3
SEC form 8
2025-10-03 06:25 ET
Cardinal Health published news for 2025 q3
SEC form 8
2025-08-14 21:06 ET
Cardinal Health published news for 2025 q2
SEC form 8
2025-08-14 21:06 ET
Cardinal Health published news for 2025 q2
SEC form 10
2025-08-12 12:58 ET
Cardinal Health reported for 2025 q2
SEC form 8
2025-08-12 10:59 ET
Cardinal Health published news for 2025 q2
SEC form 8
2025-08-12 10:59 ET
Cardinal Health reported for 2025 q2
SEC form 8
2025-08-12 10:59 ET
Cardinal Health published news for 2025 q2
SEC form 8
2025-06-12 10:47 ET
Cardinal Health published news for 2025 q1
SEC form 8
2025-06-12 10:47 ET
Cardinal Health published news for 2025 q1
SEC form 10
2025-05-01 12:53 ET
Cardinal Health reported for 2025 q1
SEC form 8
2025-05-01 10:49 ET
Cardinal Health published news for 2025 q1
SEC form 8
2025-05-01 10:49 ET
Cardinal Health reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Cardinal Health reported for 2025 q1
SEC form 10
2025-01-30 08:48 ET
Cardinal Health reported for 2024 q4
SEC form 8
2025-01-30 06:51 ET
Cardinal Health published news for 2024 q4
SEC form 8
2025-01-30 06:51 ET
Cardinal Health reported for 2024 q4
SEC form 10
2025-01-30 00:00 ET
Cardinal Health reported for 2024 q4
SEC form 10
2024-11-01 08:58 ET
Cardinal Health reported for 2024 q3
SEC form 8
2024-11-01 06:47 ET
Cardinal Health reported for 2024 q3
SEC form 8
2024-11-01 06:47 ET
Cardinal Health published news for 2024 q3
SEC form 10
2024-08-14 08:47 ET
Cardinal Health reported for 2024 q2
SEC form 8
2024-08-14 06:36 ET
Cardinal Health published news for 2024 q2
SEC form 8
2024-08-14 06:36 ET
Cardinal Health reported for 2024 q2
SEC form 10
2024-08-14 00:00 ET
Cardinal Health reported for 2024 q2
SEC form 10
2024-05-02 08:47 ET
Cardinal Health reported for 2024 q1
SEC form 8
2024-05-02 06:50 ET
Cardinal Health published news for 2024 q1
SEC form 8
2024-05-02 06:50 ET
Cardinal Health reported for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Cardinal Health reported for 2024 q1
SEC form 10
2024-02-01 00:00 ET
Cardinal Health reported for 2023 q4
SEC form 8
2024-02-01 00:00 ET
Cardinal Health published news for 2023 q4
SEC form 8
2024-02-01 00:00 ET
Cardinal Health reported for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Cardinal Health published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Cardinal Health published news for 2023 q4
SEC form 10
2023-11-03 08:45 ET
Cardinal Health reported for 2023 q3
SEC form 8
2023-11-03 07:00 ET
Cardinal Health reported for 2023 q3
SEC form 10
2023-08-15 08:50 ET
Cardinal Health reported for 2023 q2
SEC form 6
2023-08-15 07:01 ET
Cardinal Health reported for 2023 q2
SEC form 8
2023-08-15 00:00 ET
Cardinal Health published news for 2023 q2
SEC form 10
2023-08-15 00:00 ET
Cardinal Health published news for 2023 q2
SEC form 6
2023-06-23 08:29 ET
Cardinal Health published news for 2023 q1
SEC form 6
2023-06-23 08:28 ET
Cardinal Health published news for 2023 q1
SEC form 6
2023-06-08 06:57 ET
Cardinal Health published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Cardinal Health reported for 2023 q1
SEC form 8
2023-02-02 00:00 ET
Cardinal Health reported for 2022 q4
SEC form 10
2023-02-02 00:00 ET
Cardinal Health reported for 2022 q4
SEC form 8
2022-11-04 00:00 ET
Cardinal Health reported for 2022 q3
SEC form 10
2022-11-04 00:00 ET
Cardinal Health reported for 2022 q3
SEC form 8
2022-08-11 00:00 ET
Cardinal Health reported for 2022 q2
SEC form 10
2022-08-11 00:00 ET
Cardinal Health reported for 2022 q2
SEC form 8
2022-05-05 00:00 ET
Cardinal Health reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Cardinal Health reported for 2022 q1
SEC form 8
2022-02-03 00:00 ET
Cardinal Health published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
Cardinal Health published news for 2021 q4
SEC form 10
2021-11-09 00:00 ET
Cardinal Health published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Cardinal Health published news for 2021 q3
SEC form 10
2021-08-16 00:00 ET
Cardinal Health published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Cardinal Health published news for 2021 q2
SEC form 10
2021-05-06 00:00 ET
Cardinal Health published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Cardinal Health published news for 2021 q1